1,534
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Protective role of emodin in rats with post-myocardial infarction heart failure and influence on extracellular signal-regulated kinase pathway

&
Pages 10246-10253 | Received 08 Aug 2021, Accepted 17 Sep 2021, Published online: 27 Nov 2021

Figures & data

Figure 1. Cardiac function indices. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, P < 0.05 vs. low-dose group, P < 0.05 vs. middle-dose group

Figure 1. Cardiac function indices. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, ∆P < 0.05 vs. low-dose group, ☆P < 0.05 vs. middle-dose group

Figure 2. Apoptosis of myocardial cells (×400). *P < 0.05 vs. sham group, #P < 0.05 vs. model group, P < 0.05 vs. low-dose group, P < 0.05 vs. middle-dose group

Figure 2. Apoptosis of myocardial cells (×400). *P < 0.05 vs. sham group, #P < 0.05 vs. model group, ∆P < 0.05 vs. low-dose group, ☆P < 0.05 vs. middle-dose group

Figure 3. Serum contents of cTnI and PGC-1. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, P < 0.05 vs. low-dose group, P < 0.05 vs. middle-dose group

Figure 3. Serum contents of cTnI and PGC-1. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, ∆P < 0.05 vs. low-dose group, ☆P < 0.05 vs. middle-dose group

Figure 4. Expressions of complex I and p-ERK in myocardial tissues. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, P < 0.05 vs. low-dose group, P < 0.05 vs. middle-dose group

Figure 4. Expressions of complex I and p-ERK in myocardial tissues. *P < 0.05 vs. sham group, #P < 0.05 vs. model group, ∆P < 0.05 vs. low-dose group, ☆P < 0.05 vs. middle-dose group